QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases 期刊论文 JOURNAL OF NEURO-ONCOLOGY, 2017, 卷号: 135, 期号: 2 作者:  Ge, Mengxi;  Zhuang, Yingjie;  Zhou, Xinli;  Huang, Ruofan;  Liang, Xiaohua 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Brain metastases  Non-small cell lung cancer  Epidermal growth factor receptor  Tyrosine kinase inhibitor   Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram 期刊论文 BMC CANCER, 2017, 卷号: 17 作者:  Ji, Xiaoyu;  Zhuang, Yingjie;  Yin, Xiangye;  Zhan, Qiong;  Zhou, Xinli 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Non-small-cell lung cancer  Brain metastases  Prognostic indexes  Intracranial surgery  Nomogram   High Probability and Frequency of EGFR Mutations in Non-Small Cell Lung Cancer with Brain Metastases 会议论文 作者:  Ge, M.;  Zhan, Q.;  Huang, R.;  Zhou, X.;  Liang, X. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 non-small cell lung cancer  Epidermal growth factor receptor  brain metastases   High dose of nimustine as an add-on treatment for small cell lung cancer with intracranial metastasis 期刊论文 Medicine (Baltimore), 2017, 卷号: Vol.96 No.41, 页码: e8218 作者:  Wei Luo;  Ya-lun Li;  Ya Juan Chen;  Qing Xiang;  Hong Chen 收藏  |  浏览/下载：1/0  |  提交时间：2019/02/25 high dose  intracranial metastases  lung cancer  nimustine   Risk Factors of Brain Metastasis during the Course of EGFR-TKIs Therapy for Patients with EGFR-Mutated Advanced Lung Adenocarcinoma 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1, 页码: S1484-S1484 作者:  Zhu, Hui;  Ma, Xiaoyan;  Yu, Jinming 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 brain metastases  risk factors  Epidermal growth factor receptor  advanced lung adenocarcinoma   Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases 期刊论文 慢性疾病与转化医学, 2017, 卷号: 3, 期号: 4, 页码: 221-229 作者:  Kong Lingling;  Wang Linlin;  Xing Ligang;  Yu Jinming 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Non-small cell lung cancer  Brain metastases  Epidermal growth factor receptor mutation  Tyrosine kinase inhibitors  Therapeutic outcomes   Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC) 期刊论文 ONCOTARGET, 2017, 卷号: 8, 期号: 8, 页码: 13304-13311 作者:  Zhu, Qianqian;  Sun, Yanan;  Cui, Yingying;  Ye, Ke;  Yang, Chengliang 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11 non-small cell lung cancer  brain metastases  epidermal growth factor  receptor  tyrosine kinase inhibitors  radiotherapy   Recurrent Response to Advanced NSCLC with Erlotinib Developing Central Nervous System Failure during Gefitinib or Icotinib Treatment 期刊论文 2017, 卷号: 12, 期号: 11, 页码: S2127-S2128 作者:  Ma, D.;  Xing, P.;  Li, J. 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04 brain metastases  Non-small-cell lung cancer  Epidermal growth factor receptor tyrosine kinase inhibitor   Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice 期刊论文 ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38 - 收藏  |  浏览/下载：5/0  |  提交时间：2020/10/26 BRAIN METASTASES  CEREBROSPINAL-FLUID  GEFITINIB  INHIBITORS  CARCINOMA  RADIATION  ERLOTINIB  afatinib  tyrosine kinase inhibitor  non-small cell lung cancer  brain metastasis  pharmacokinetic/pharmacodynamics  pEGFR